-
Je něco špatně v tomto záznamu ?
Evaluation of collagen/hydroxyapatite electrospun layers loaded with vancomycin, gentamicin and their combination: Comparison of release kinetics, antimicrobial activity and cytocompatibility
T. Suchý, M. Šupová, P. Sauerová, M. Hubálek Kalbáčová, E. Klapková, M. Pokorný, L. Horný, J. Závora, R. Ballay, F. Denk, M. Sojka, L. Vištejnová,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
Odkazy
PubMed
31055065
DOI
10.1016/j.ejpb.2019.04.021
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky chemie farmakologie MeSH
- buněčné linie MeSH
- Enterococcus faecalis účinky léků MeSH
- gentamiciny chemie farmakologie MeSH
- hydroxyapatit chemie MeSH
- infekce spojené s protézou mikrobiologie prevence a kontrola MeSH
- kinetika MeSH
- kolagen chemie MeSH
- kostní cementy chemie MeSH
- lidé MeSH
- methicilin rezistentní Staphylococcus aureus účinky léků MeSH
- mikrobiální testy citlivosti metody MeSH
- Staphylococcus epidermidis účinky léků MeSH
- synergismus léků MeSH
- vankomycin chemie farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The aim of this study was to develop a biodegradable nanostructured electrospun layer based on collagen (COL), hydroxyapatite nanoparticles (HA), vancomycin hydrochloride (V), gentamicin sulphate (G) and their combination (VG) for the treatment of prosthetic joint infections and the prevention of infection during the joint replacement procedure. COL/HA layers containing different amounts of HA (0, 5 and 15 wt%) were tested for the in vitro release kinetics of antibiotics, antimicrobial activity against MRSA, gentamicin-resistant Staphylococcus epidermidis and Enterococcus faecalis isolates and cytocompatibility using SAOS-2 bone-like cells. The results revealed that the COL/HA layers released high concentrations of vancomycin and gentamicin for 21 days and performed effectively against the tested clinically-relevant bacterial isolates. The presence of HA in the collagen layers was found not to affect the release kinetics of the vancomycin from the layers loaded only with vancomycin or its combination with gentamicin. Conversely, the presence of HA slowed down the release of gentamicin from the COL/HA layers loaded with gentamicin and its combination with vancomycin. The combination of both antibiotics exerted a positive effect on the prolongation of the conversion of vancomycin into its degradation products. All the layers tested with different antibiotics exhibited potential antibacterial activity with respect to both the tested staphylococci isolates and enterococci. The complemental effect of vancomycin was determined against both gentamicin-resistant Staphylococcus epidermidis and Enterococcus faecalis in contrast to the application of gentamicin as a single agent. This combination was also found to be more effective against MRSA than is vancomycin as a single agent. Importantly, this combination of vancomycin and gentamicin in the COL/HA layers exhibited sufficient cytocompatibility to SAOS-2, which was independent of the HA content. Conversely, only gentamicin caused the death of SAOS-2 independently of HA content and only vancomycin stimulated SAOS-2 behaviour with an increased concentration of HA in the COL/HA layers. In conclusion, COL/HA layers with 15 wt% of HA impregnated with vancomycin or with a combination of vancomycin and gentamicin offer a promising treatment approach and the potential to prevent infection during the joint replacement procedures.
Biomedical Centre Faculty of Medicine in Pilsen Charles University Prague Pilsen Czech Republic
Contipro a s R and D Department Dolni Dobrouc Czech Republic
Faculty of Mechanical Engineering Czech Technical University Prague Prague 6 Czech Republic
Faculty of Medicine Charles University Prague and Motol University Hospital Prague 5 Czech Republic
Institute ofMicrobiology Faculty of Medicine Slovak Medical University Bratislava Slovakia
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044844
- 003
- CZ-PrNML
- 005
- 20200114083128.0
- 007
- ta
- 008
- 200109s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejpb.2019.04.021 $2 doi
- 035 __
- $a (PubMed)31055065
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Suchý, Tomáš $u Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, Academy of Sciences of the Czech Republic, Prague 8, Czech Republic; Faculty of Mechanical Engineering, Czech Technical University in Prague, Prague 6, Czech Republic; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic. Electronic address: suchyt@irsm.cas.cz.
- 245 10
- $a Evaluation of collagen/hydroxyapatite electrospun layers loaded with vancomycin, gentamicin and their combination: Comparison of release kinetics, antimicrobial activity and cytocompatibility / $c T. Suchý, M. Šupová, P. Sauerová, M. Hubálek Kalbáčová, E. Klapková, M. Pokorný, L. Horný, J. Závora, R. Ballay, F. Denk, M. Sojka, L. Vištejnová,
- 520 9_
- $a The aim of this study was to develop a biodegradable nanostructured electrospun layer based on collagen (COL), hydroxyapatite nanoparticles (HA), vancomycin hydrochloride (V), gentamicin sulphate (G) and their combination (VG) for the treatment of prosthetic joint infections and the prevention of infection during the joint replacement procedure. COL/HA layers containing different amounts of HA (0, 5 and 15 wt%) were tested for the in vitro release kinetics of antibiotics, antimicrobial activity against MRSA, gentamicin-resistant Staphylococcus epidermidis and Enterococcus faecalis isolates and cytocompatibility using SAOS-2 bone-like cells. The results revealed that the COL/HA layers released high concentrations of vancomycin and gentamicin for 21 days and performed effectively against the tested clinically-relevant bacterial isolates. The presence of HA in the collagen layers was found not to affect the release kinetics of the vancomycin from the layers loaded only with vancomycin or its combination with gentamicin. Conversely, the presence of HA slowed down the release of gentamicin from the COL/HA layers loaded with gentamicin and its combination with vancomycin. The combination of both antibiotics exerted a positive effect on the prolongation of the conversion of vancomycin into its degradation products. All the layers tested with different antibiotics exhibited potential antibacterial activity with respect to both the tested staphylococci isolates and enterococci. The complemental effect of vancomycin was determined against both gentamicin-resistant Staphylococcus epidermidis and Enterococcus faecalis in contrast to the application of gentamicin as a single agent. This combination was also found to be more effective against MRSA than is vancomycin as a single agent. Importantly, this combination of vancomycin and gentamicin in the COL/HA layers exhibited sufficient cytocompatibility to SAOS-2, which was independent of the HA content. Conversely, only gentamicin caused the death of SAOS-2 independently of HA content and only vancomycin stimulated SAOS-2 behaviour with an increased concentration of HA in the COL/HA layers. In conclusion, COL/HA layers with 15 wt% of HA impregnated with vancomycin or with a combination of vancomycin and gentamicin offer a promising treatment approach and the potential to prevent infection during the joint replacement procedures.
- 650 _2
- $a antibakteriální látky $x chemie $x farmakologie $7 D000900
- 650 _2
- $a kostní cementy $x chemie $7 D001843
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a kolagen $x chemie $7 D003094
- 650 _2
- $a synergismus léků $7 D004357
- 650 _2
- $a hydroxyapatit $x chemie $7 D017886
- 650 _2
- $a Enterococcus faecalis $x účinky léků $7 D013293
- 650 _2
- $a gentamiciny $x chemie $x farmakologie $7 D005839
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a methicilin rezistentní Staphylococcus aureus $x účinky léků $7 D055624
- 650 _2
- $a mikrobiální testy citlivosti $x metody $7 D008826
- 650 _2
- $a infekce spojené s protézou $x mikrobiologie $x prevence a kontrola $7 D016459
- 650 _2
- $a Staphylococcus epidermidis $x účinky léků $7 D013212
- 650 _2
- $a vankomycin $x chemie $x farmakologie $7 D014640
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šupová, Monika $u Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, Academy of Sciences of the Czech Republic, Prague 8, Czech Republic; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 700 1_
- $a Sauerová, Pavla $u Institute of Pathological Physiology, 1(st) Faculty of Medicine, Charles University in Prague, Prague, Czech Republic; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 700 1_
- $a Hubálek Kalbáčová, Marie $u Institute of Pathological Physiology, 1(st) Faculty of Medicine, Charles University in Prague, Prague, Czech Republic; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 700 1_
- $a Klapková, Eva $u Department of Medical Chemistry and Clinical Biochemistry, Charles University, 2(nd) Medical School and University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Pokorný, Marek $u Contipro a.s., R&D Department, Dolni Dobrouc, Czech Republic.
- 700 1_
- $a Horný, Lukáš $u Faculty of Mechanical Engineering, Czech Technical University in Prague, Prague 6, Czech Republic; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 700 1_
- $a Závora, Jan $u Clinical Microbiology and ATB Centre, Institute of Medical Biochemistry and Laboratory Diagnostics, 1(st) Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague 2, Czech Republic.
- 700 1_
- $a Ballay, Rastislav $u 1(st) Department of Orthopaedics, 1(st) Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague 5, Czech Republic.
- 700 1_
- $a Denk, František $u Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, Academy of Sciences of the Czech Republic, Prague 8, Czech Republic.
- 700 1_
- $a Sojka, Martin $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic; Institute ofMicrobiology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
- 700 1_
- $a Vištejnová, Lucie $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 773 0_
- $w MED00001640 $t European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V $x 1873-3441 $g Roč. 140, č. - (2019), s. 50-59
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31055065 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200114083500 $b ABA008
- 999 __
- $a ok $b bmc $g 1483113 $s 1083517
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 140 $c - $d 50-59 $e 20190502 $i 1873-3441 $m European journal of pharmaceutics and biopharmaceutics $n Eur J Pharm Biopharm $x MED00001640
- LZP __
- $a Pubmed-20200109